 | • レポートコード：MRC2102QY8684 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の医療用止血剤市場について種類別（ゲル化スポンジ、酸化再生セルロース系止血鉗子、その他）、用途別（病院、手術センター、クリニック、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・医療用止血剤市場の概要 ・世界の主要地域別医療用止血剤市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の医療用止血剤市場規模2015-2026：種類別（ゲル化スポンジ、酸化再生セルロース系止血鉗子、その他） ・世界の医療用止血剤市場規模2015-2026：用途別（病院、手術センター、クリニック、その他） ・医療用止血剤の米国市場規模2015-2020 ・医療用止血剤のヨーロッパ市場規模2015-2020 ・医療用止血剤の中国市場規模2015-2020 ・医療用止血剤の日本市場規模2015-2020 ・医療用止血剤の東南アジア市場規模2015-2020 ・医療用止血剤のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・医療用止血剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・医療用止血剤の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Medical Hemostatic Agents Market
The global Medical Hemostatic Agents market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Medical Hemostatic Agents Scope and Market Size
The global Medical Hemostatic Agents market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Medical Hemostatic Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Medical Hemostatic Agents market is segmented into
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Segment by Application, the Medical Hemostatic Agents market is segmented into
Hospitals
Surgical Centers
Clnics
Others
The Medical Hemostatic Agents market is analysed and market size information is provided by regions (countries). Segment by Application, the Medical Hemostatic Agents market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Medical Hemostatic Agents Market Share Analysis
Medical Hemostatic Agents market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Medical Hemostatic Agents business, the date to enter into the Medical Hemostatic Agents market, Medical Hemostatic Agents product introduction, recent developments, etc.
The major vendors covered:
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica
CryoLife
BioCer Entwicklungs
Biom’Up SAS
1 Medical Hemostatic Agents Market Overview
1.1 Medical Hemostatic Agents Product Scope
1.2 Medical Hemostatic Agents Segment by Type
1.2.1 Global Medical Hemostatic Agents Sales by Type (2020-2026)
1.2.2 Gelation Sponge
1.2.3 Oxidized Regenerated Cellulose Based Hemostats
1.2.4 Others
1.3 Medical Hemostatic Agents Segment by Application
1.3.1 Global Medical Hemostatic Agents Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Surgical Centers
1.3.4 Clnics
1.3.5 Others
1.4 Medical Hemostatic Agents Market Estimates and Forecasts (2015-2026)
1.4.1 Global Medical Hemostatic Agents Sales Growth Rate (2015-2026)
1.4.2 Global Medical Hemostatic Agents Revenue and Growth Rate (2015-2026)
1.4.3 Global Medical Hemostatic Agents Price Trends (2015-2026)
2 Medical Hemostatic Agents Estimate and Forecast by Region
2.1 Global Medical Hemostatic Agents Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Medical Hemostatic Agents Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Medical Hemostatic Agents Sales Market Share by Region (2015-2020)
2.2.2 Global Medical Hemostatic Agents Revenue Market Share by Region (2015-2020)
2.3 Global Medical Hemostatic Agents Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Medical Hemostatic Agents Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Medical Hemostatic Agents Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Medical Hemostatic Agents Estimates and Projections (2015-2026)
2.4.2 Europe Medical Hemostatic Agents Estimates and Projections (2015-2026)
2.4.3 China Medical Hemostatic Agents Estimates and Projections (2015-2026)
2.4.4 Japan Medical Hemostatic Agents Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Medical Hemostatic Agents Estimates and Projections (2015-2026)
2.4.6 India Medical Hemostatic Agents Estimates and Projections (2015-2026)
3 Global Medical Hemostatic Agents Competition Landscape by Players
3.1 Global Top Medical Hemostatic Agents Players by Sales (2015-2020)
3.2 Global Top Medical Hemostatic Agents Players by Revenue (2015-2020)
3.3 Global Medical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medical Hemostatic Agents as of 2019)
3.4 Global Medical Hemostatic Agents Average Price by Company (2015-2020)
3.5 Manufacturers Medical Hemostatic Agents Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Medical Hemostatic Agents Players (Opinion Leaders)
4 Global Medical Hemostatic Agents Market Size by Type
4.1 Global Medical Hemostatic Agents Historic Market Review by Type (2015-2020)
4.1.1 Global Medical Hemostatic Agents Sales Market Share by Type (2015-2020)
4.1.2 Global Medical Hemostatic Agents Revenue Market Share by Type (2015-2020)
4.1.3 Global Medical Hemostatic Agents Price by Type (2015-2020)
4.2 Global Medical Hemostatic Agents Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Medical Hemostatic Agents Sales Forecast by Type (2021-2026)
4.2.2 Global Medical Hemostatic Agents Revenue Forecast by Type (2021-2026)
4.2.3 Global Medical Hemostatic Agents Price Forecast by Type (2021-2026)
5 Global Medical Hemostatic Agents Market Size by Application
5.1 Global Medical Hemostatic Agents Historic Market Review by Application (2015-2020)
5.1.1 Global Medical Hemostatic Agents Sales Market Share by Application (2015-2020)
5.1.2 Global Medical Hemostatic Agents Revenue Market Share by Application (2015-2020)
5.1.3 Global Medical Hemostatic Agents Price by Application (2015-2020)
5.2 Global Medical Hemostatic Agents Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Medical Hemostatic Agents Sales Forecast by Application (2021-2026)
5.2.2 Global Medical Hemostatic Agents Revenue Forecast by Application (2021-2026)
5.2.3 Global Medical Hemostatic Agents Price Forecast by Application (2021-2026)
6 United States Medical Hemostatic Agents Market Facts & Figures
6.1 United States Medical Hemostatic Agents Sales Market Share by Company (2015-2020)
6.2 United States Medical Hemostatic Agents Sales Market Share by Type (2015-2020)
6.3 United States Medical Hemostatic Agents Sales Market Share by Application (2015-2020)
7 Europe Medical Hemostatic Agents Market Facts & Figures
7.1 Europe Medical Hemostatic Agents Sales Market Share by Company (2015-2020)
7.2 Europe Medical Hemostatic Agents Sales Market Share by Type (2015-2020)
7.3 Europe Medical Hemostatic Agents Sales Market Share by Application (2015-2020)
8 China Medical Hemostatic Agents Market Facts & Figures
8.1 China Medical Hemostatic Agents Sales Market Share by Company (2015-2020)
8.2 China Medical Hemostatic Agents Sales Market Share by Type (2015-2020)
8.3 China Medical Hemostatic Agents Sales Market Share by Application (2015-2020)
9 Japan Medical Hemostatic Agents Market Facts & Figures
9.1 Japan Medical Hemostatic Agents Sales Market Share by Company (3015-3030)
9.2 Japan Medical Hemostatic Agents Sales Market Share by Type (2015-2020)
9.3 Japan Medical Hemostatic Agents Sales Market Share by Application (2015-2020)
10 Southeast Asia Medical Hemostatic Agents Market Facts & Figures
10.1 Southeast Asia Medical Hemostatic Agents Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Medical Hemostatic Agents Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Medical Hemostatic Agents Sales Market Share by Application (2015-2020)
11 India Medical Hemostatic Agents Market Facts & Figures
11.1 India Medical Hemostatic Agents Sales Market Share by Company (2015-2020)
11.2 India Medical Hemostatic Agents Sales Market Share by Type (2015-2020)
11.3 India Medical Hemostatic Agents Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Medical Hemostatic Agents Business
12.1 Ethicon
12.1.1 Ethicon Corporation Information
12.1.2 Ethicon Business Overview
12.1.3 Ethicon Medical Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Ethicon Medical Hemostatic Agents Products Offered
12.1.5 Ethicon Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Business Overview
12.2.3 Pfizer Medical Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Medical Hemostatic Agents Products Offered
12.2.5 Pfizer Recent Development
12.3 Baxter International
12.3.1 Baxter International Corporation Information
12.3.2 Baxter International Business Overview
12.3.3 Baxter International Medical Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Baxter International Medical Hemostatic Agents Products Offered
12.3.5 Baxter International Recent Development
12.4 C. R. Bard
12.4.1 C. R. Bard Corporation Information
12.4.2 C. R. Bard Business Overview
12.4.3 C. R. Bard Medical Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.4.4 C. R. Bard Medical Hemostatic Agents Products Offered
12.4.5 C. R. Bard Recent Development
12.5 The Medicines Company
12.5.1 The Medicines Company Corporation Information
12.5.2 The Medicines Company Business Overview
12.5.3 The Medicines Company Medical Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.5.4 The Medicines Company Medical Hemostatic Agents Products Offered
12.5.5 The Medicines Company Recent Development
12.6 Anika Therapeutics
12.6.1 Anika Therapeutics Corporation Information
12.6.2 Anika Therapeutics Business Overview
12.6.3 Anika Therapeutics Medical Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Anika Therapeutics Medical Hemostatic Agents Products Offered
12.6.5 Anika Therapeutics Recent Development
12.7 Advanced Medical Solutions
12.7.1 Advanced Medical Solutions Corporation Information
12.7.2 Advanced Medical Solutions Business Overview
12.7.3 Advanced Medical Solutions Medical Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Advanced Medical Solutions Medical Hemostatic Agents Products Offered
12.7.5 Advanced Medical Solutions Recent Development
12.8 Integra LifeSciences
12.8.1 Integra LifeSciences Corporation Information
12.8.2 Integra LifeSciences Business Overview
12.8.3 Integra LifeSciences Medical Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Integra LifeSciences Medical Hemostatic Agents Products Offered
12.8.5 Integra LifeSciences Recent Development
12.9 B Braun Melsungen
12.9.1 B Braun Melsungen Corporation Information
12.9.2 B Braun Melsungen Business Overview
12.9.3 B Braun Melsungen Medical Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.9.4 B Braun Melsungen Medical Hemostatic Agents Products Offered
12.9.5 B Braun Melsungen Recent Development
12.10 Gelita Medical
12.10.1 Gelita Medical Corporation Information
12.10.2 Gelita Medical Business Overview
12.10.3 Gelita Medical Medical Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Gelita Medical Medical Hemostatic Agents Products Offered
12.10.5 Gelita Medical Recent Development
12.11 Equimedical
12.11.1 Equimedical Corporation Information
12.11.2 Equimedical Business Overview
12.11.3 Equimedical Medical Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Equimedical Medical Hemostatic Agents Products Offered
12.11.5 Equimedical Recent Development
12.12 Vascular Solutions
12.12.1 Vascular Solutions Corporation Information
12.12.2 Vascular Solutions Business Overview
12.12.3 Vascular Solutions Medical Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Vascular Solutions Medical Hemostatic Agents Products Offered
12.12.5 Vascular Solutions Recent Development
12.13 Marine Polymer Technologies
12.13.1 Marine Polymer Technologies Corporation Information
12.13.2 Marine Polymer Technologies Business Overview
12.13.3 Marine Polymer Technologies Medical Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Marine Polymer Technologies Medical Hemostatic Agents Products Offered
12.13.5 Marine Polymer Technologies Recent Development
12.14 Z-Medica
12.14.1 Z-Medica Corporation Information
12.14.2 Z-Medica Business Overview
12.14.3 Z-Medica Medical Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Z-Medica Medical Hemostatic Agents Products Offered
12.14.5 Z-Medica Recent Development
12.15 CryoLife
12.15.1 CryoLife Corporation Information
12.15.2 CryoLife Business Overview
12.15.3 CryoLife Medical Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.15.4 CryoLife Medical Hemostatic Agents Products Offered
12.15.5 CryoLife Recent Development
12.16 BioCer Entwicklungs
12.16.1 BioCer Entwicklungs Corporation Information
12.16.2 BioCer Entwicklungs Business Overview
12.16.3 BioCer Entwicklungs Medical Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.16.4 BioCer Entwicklungs Medical Hemostatic Agents Products Offered
12.16.5 BioCer Entwicklungs Recent Development
12.17 Biom’Up SAS
12.17.1 Biom’Up SAS Corporation Information
12.17.2 Biom’Up SAS Business Overview
12.17.3 Biom’Up SAS Medical Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Biom’Up SAS Medical Hemostatic Agents Products Offered
12.17.5 Biom’Up SAS Recent Development
13 Medical Hemostatic Agents Manufacturing Cost Analysis
13.1 Medical Hemostatic Agents Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Medical Hemostatic Agents
13.4 Medical Hemostatic Agents Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Medical Hemostatic Agents Distributors List
14.3 Medical Hemostatic Agents Customers
15 Market Dynamics
15.1 Medical Hemostatic Agents Market Trends
15.2 Medical Hemostatic Agents Opportunities and Drivers
15.3 Medical Hemostatic Agents Market Challenges
15.4 Medical Hemostatic Agents Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Medical Hemostatic Agents Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Medical Hemostatic Agents Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Medical Hemostatic Agents Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Medical Hemostatic Agents Sales (K Units) by Region (2015-2020)
Table 5. Global Medical Hemostatic Agents Sales Market Share by Region (2015-2020)
Table 6. Global Medical Hemostatic Agents Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Medical Hemostatic Agents Revenue Share by Region (2015-2020)
Table 8. Global Medical Hemostatic Agents Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Medical Hemostatic Agents Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Medical Hemostatic Agents Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Medical Hemostatic Agents Revenue Share Forecast by Region (2021-2026)
Table 12. Global Medical Hemostatic Agents (K Units) of Key Companies (2015-2020)
Table 13. Global Medical Hemostatic Agents Sales Share by Company (2015-2020)
Table 14. Global Medical Hemostatic Agents Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Medical Hemostatic Agents Revenue Share by Company (2015-2020)
Table 16. Global Medical Hemostatic Agents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medical Hemostatic Agents as of 2019)
Table 17. Global Medical Hemostatic Agents Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Medical Hemostatic Agents Manufacturing Sites and Area Served
Table 19. Manufacturers Medical Hemostatic Agents Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Medical Hemostatic Agents Players
Table 22. Global Medical Hemostatic Agents Sales (K Units) by Type (2015-2020)
Table 23. Global Medical Hemostatic Agents Sales Share by Type (2015-2020)
Table 24. Global Medical Hemostatic Agents Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Medical Hemostatic Agents Price (K Units) by Type (2015-2020)
Table 26. Global Medical Hemostatic Agents Sales Share by Type (2021-2026)
Table 27. Global Medical Hemostatic Agents Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Medical Hemostatic Agents Revenue Share by Type (2021-2026)
Table 29. Global Medical Hemostatic Agents Price (K Units) by Type (2021-2026)
Table 30. Global Medical Hemostatic Agents Sales (K Units) by Application (2015-2020)
Table 31. Global Medical Hemostatic Agents Sales Share by Application (2015-2020)
Table 32. Global Medical Hemostatic Agents Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Medical Hemostatic Agents Price (K Units) by Application (2015-2020)
Table 34. Global Medical Hemostatic Agents Sales (K Units) by Application (2021-2026)
Table 35. Global Medical Hemostatic Agents Sales Share by Application (2021-2026)
Table 36. Global Medical Hemostatic Agents Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Medical Hemostatic Agents Revenue Share by Application (2021-2026)
Table 38. Global Medical Hemostatic Agents Price (K Units) by Application (2021-2026)
Table 39. United States Medical Hemostatic Agents Sales (K Units) by Company (2015-2020)
Table 40. United States Medical Hemostatic Agents Sales Market Share by Company (2015-2020)
Table 41. United States Medical Hemostatic Agents Sales (K Units) by Type (2015-2020)
Table 42. United States Medical Hemostatic Agents Sales Market Share by Type (2015-2020)
Table 43. United States Medical Hemostatic Agents Sales (K Units) by Application (2015-2020)
Table 44. United States Medical Hemostatic Agents Sales Market Share by Application (2015-2020)
Table 45. Europe Medical Hemostatic Agents Sales (K Units) by Company (2015-2020)
Table 46. Europe Medical Hemostatic Agents Sales Market Share by Company (2015-2020)
Table 47. Europe Medical Hemostatic Agents Sales (K Units) by Type (2015-2020)
Table 48. Europe Medical Hemostatic Agents Sales Market Share by Type (2015-2020)
Table 49. Europe Medical Hemostatic Agents Sales (K Units) by Application (2015-2020)
Table 50. Europe Medical Hemostatic Agents Sales Market Share by Type (2015-2020)
Table 51. China Medical Hemostatic Agents Sales (K Units) by Company (2015-2020)
Table 52. China Medical Hemostatic Agents Sales Market Share by Company (2015-2020)
Table 53. China Medical Hemostatic Agents Sales (K Units) by Type (2015-2020)
Table 54. China Medical Hemostatic Agents Sales Market Share by Type (2015-2020)
Table 55. China Medical Hemostatic Agents Sales (K Units) by Application (2015-2020)
Table 56. China Medical Hemostatic Agents Sales Market Share by Application (2015-2020)
Table 57. Japan Medical Hemostatic Agents Sales (K Units) by Company (2015-2020)
Table 58. Japan Medical Hemostatic Agents Sales Market Share by Company (2015-2020)
Table 59. Japan Medical Hemostatic Agents Sales (K Units) by Type (2015-2020)
Table 60. Japan Medical Hemostatic Agents Sales Market Share by Type (2015-2020)
Table 61. Japan Medical Hemostatic Agents Sales (K Units) by Application (2015-2020)
Table 62. Japan Medical Hemostatic Agents Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Medical Hemostatic Agents Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Medical Hemostatic Agents Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Medical Hemostatic Agents Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Medical Hemostatic Agents Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Medical Hemostatic Agents Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Medical Hemostatic Agents Sales Market Share by Application (2015-2020)
Table 69. India Medical Hemostatic Agents Sales (K Units) by Company (2015-2020)
Table 70. India Medical Hemostatic Agents Sales Market Share by Company (2015-2020)
Table 71. India Medical Hemostatic Agents Sales (K Units) by Type (2015-2020)
Table 72. India Medical Hemostatic Agents Sales Market Share by Type (2015-2020)
Table 73. India Medical Hemostatic Agents Sales (K Units) by Application (2015-2020)
Table 74. India Medical Hemostatic Agents Sales Market Share by Application (2015-2020)
Table 75. Ethicon Corporation Information
Table 76. Ethicon Description and Business Overview
Table 77. Ethicon Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Ethicon Medical Hemostatic Agents Product
Table 79. Ethicon Recent Development
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Pfizer Medical Hemostatic Agents Product
Table 84. Pfizer Recent Development
Table 85. Baxter International Corporation Information
Table 86. Baxter International Description and Business Overview
Table 87. Baxter International Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Baxter International Medical Hemostatic Agents Product
Table 89. Baxter International Recent Development
Table 90. C. R. Bard Corporation Information
Table 91. C. R. Bard Description and Business Overview
Table 92. C. R. Bard Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. C. R. Bard Medical Hemostatic Agents Product
Table 94. C. R. Bard Recent Development
Table 95. The Medicines Company Corporation Information
Table 96. The Medicines Company Description and Business Overview
Table 97. The Medicines Company Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. The Medicines Company Medical Hemostatic Agents Product
Table 99. The Medicines Company Recent Development
Table 100. Anika Therapeutics Corporation Information
Table 101. Anika Therapeutics Description and Business Overview
Table 102. Anika Therapeutics Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Anika Therapeutics Medical Hemostatic Agents Product
Table 104. Anika Therapeutics Recent Development
Table 105. Advanced Medical Solutions Corporation Information
Table 106. Advanced Medical Solutions Description and Business Overview
Table 107. Advanced Medical Solutions Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Advanced Medical Solutions Medical Hemostatic Agents Product
Table 109. Advanced Medical Solutions Recent Development
Table 110. Integra LifeSciences Corporation Information
Table 111. Integra LifeSciences Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Integra LifeSciences Description and Business Overview
Table 113. Integra LifeSciences Medical Hemostatic Agents Product
Table 114. Integra LifeSciences Recent Development
Table 115. B Braun Melsungen Corporation Information
Table 116. B Braun Melsungen Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. B Braun Melsungen Description and Business Overview
Table 118. B Braun Melsungen Medical Hemostatic Agents Product
Table 119. B Braun Melsungen Recent Development
Table 120. Gelita Medical Corporation Information
Table 121. Gelita Medical Description and Business Overview
Table 122. Gelita Medical Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Gelita Medical Medical Hemostatic Agents Product
Table 124. Gelita Medical Recent Development
Table 125. Equimedical Corporation Information
Table 126. Equimedical Description and Business Overview
Table 127. Equimedical Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Equimedical Medical Hemostatic Agents Product
Table 129. Equimedical Recent Development
Table 130. Vascular Solutions Corporation Information
Table 131. Vascular Solutions Description and Business Overview
Table 132. Vascular Solutions Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Vascular Solutions Medical Hemostatic Agents Product
Table 134. Vascular Solutions Recent Development
Table 135. Marine Polymer Technologies Corporation Information
Table 136. Marine Polymer Technologies Description and Business Overview
Table 137. Marine Polymer Technologies Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Marine Polymer Technologies Medical Hemostatic Agents Product
Table 139. Marine Polymer Technologies Recent Development
Table 140. Z-Medica Corporation Information
Table 141. Z-Medica Description and Business Overview
Table 142. Z-Medica Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Z-Medica Medical Hemostatic Agents Product
Table 144. Z-Medica Recent Development
Table 145. CryoLife Corporation Information
Table 146. CryoLife Description and Business Overview
Table 147. CryoLife Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. CryoLife Medical Hemostatic Agents Product
Table 149. CryoLife Recent Development
Table 150. BioCer Entwicklungs Corporation Information
Table 151. BioCer Entwicklungs Description and Business Overview
Table 152. BioCer Entwicklungs Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. BioCer Entwicklungs Medical Hemostatic Agents Product
Table 154. BioCer Entwicklungs Recent Development
Table 155. Biom’Up SAS Corporation Information
Table 156. Biom’Up SAS Description and Business Overview
Table 157. Biom’Up SAS Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. Biom’Up SAS Medical Hemostatic Agents Product
Table 159. Biom’Up SAS Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Medical Hemostatic Agents Distributors List
Table 163. Medical Hemostatic Agents Customers List
Table 164. Medical Hemostatic Agents Market Key Trends
Table 165. Medical Hemostatic Agents Key Opportunities and Drivers
Table 166. Medical Hemostatic Agents Market Challenges
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Medical Hemostatic Agents Product Picture
Figure 2. Global Medical Hemostatic Agents Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Medical Hemostatic Agents Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Surgical Centers Examples
Figure 8. Clnics Examples
Figure 9. Others Examples
Figure 10. Global Medical Hemostatic Agents Sales (K Units) Growth Rate (2015-2026)
Figure 11. Global Medical Hemostatic Agents Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Medical Hemostatic Agents Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 13. Global Medical Hemostatic Agents Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Medical Hemostatic Agents Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Medical Hemostatic Agents Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Medical Hemostatic Agents Sales (K Units) Growth Rate (2015-2026)
Figure 17. Europe Medical Hemostatic Agents Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Medical Hemostatic Agents Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Medical Hemostatic Agents Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Medical Hemostatic Agents Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Medical Hemostatic Agents Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Medical Hemostatic Agents Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Medical Hemostatic Agents Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Medical Hemostatic Agents Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Medical Hemostatic Agents Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Medical Hemostatic Agents Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Medical Hemostatic Agents Players Market Share by Revenue in Medical Hemostatic Agents 2015 & 2019
Figure 28. Medical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Medical Hemostatic Agents Revenue Share by Type (2015-2020)
Figure 30. Global Medical Hemostatic Agents Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Medical Hemostatic Agents Revenue Share by Application (2015-2020)
Figure 32. Global Medical Hemostatic Agents Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Medical Hemostatic Agents Sales Market Share by Type in 2019
Figure 34. United States Medical Hemostatic Agents Sales Market Share by Type in 2019
Figure 35. Europe Medical Hemostatic Agents Sales Market Share by Company in 2019
Figure 36. Europe Medical Hemostatic Agents Sales Market Share by Type in 2019
Figure 37. Europe Medical Hemostatic Agents Sales Market Share by Application in 2019
Figure 38. China Medical Hemostatic Agents Sales Market Share by Company in 2019
Figure 39. China Medical Hemostatic Agents Sales Market Share by Type in 2019
Figure 40. China Medical Hemostatic Agents Sales Market Share by Application in 2019
Figure 41. Japan Medical Hemostatic Agents Sales Market Share by Company in 2019
Figure 42. Japan Medical Hemostatic Agents Sales Market Share by Type in 2019
Figure 43. Japan Medical Hemostatic Agents Sales Market Share by Application in 2019
Figure 44. Southeast Asia Medical Hemostatic Agents Sales Market Share by Company in 2019
Figure 45. Southeast Asia Medical Hemostatic Agents Sales Market Share by Type in 2019
Figure 46. Southeast Asia Medical Hemostatic Agents Sales Market Share by Application in 2019
Figure 47. India Medical Hemostatic Agents Sales Market Share by Company in 2019
Figure 48. India Medical Hemostatic Agents Sales Market Share by Type in 2019
Figure 49. India Medical Hemostatic Agents Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Medical Hemostatic Agents
Figure 52. Manufacturing Process Analysis of Medical Hemostatic Agents
Figure 53. Medical Hemostatic Agents Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
止血剤・ティッシュシール剤の世界市場レポート2020 Hemostasis is defined as "the blocking of bleeding or bleeding through blood vessels or other parts of the body".Hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.The industry is driven by a growing base of…- 止血ジェルの世界市場レポート2020 Hemostatic gel is used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.In recent years, global hemostatic gels have developed rapidly, with an average growth rate of around 7%.In 2018, global production of hemostatic gels was about 3.26 million pieces.…
- 外部止血装置の世界市場レポート2020 Market Analysis and Insights: Global External Hemostatic Device Market The global External Hemostatic Device market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global External Hemostatic Device Scope and Market Size The global Ex…
- 免疫チェックポイントエージェントの世界市場レポート2020 Market Analysis and Insights: Global Immune Checkpoint Agents Market The global Immune Checkpoint Agents market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Immune Checkpoint Agents Scope and Market Size The global Immune C…
- 光硬化剤の世界市場レポート2020 A photopolymer or light-activated resin is a polymer that changes its properties when exposed to light, often in the ultraviolet or visible region of the electromagnetic spectrum. The result of photo curing is the formation of a thermoset network of polymers. Market Analysis and Insights: Global Pho…